跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 33,113 条关于
“Atypical Hemolytic Uremic Syndrome”
全部
33,113
临床试验
29,633
药物
317
机构
15
资讯
3,148
去年
Early Platelet Count Changes Predict Ultomiris Response in aHUS Patients
2年前
4DMT's 4D-310 Shows Promising Cardiac Improvements in Fabry Disease Trial
去年
Breakthrough Treatments Transform Landscape for Rare Hemolytic Anemias: From C5 Inhibitors to Novel Therapeutic Approaches
2年前
FDA Lifts Clinical Hold on 4D Molecular Therapeutics' Fabry Disease Gene Therapy Trial
去年
Teva and Samsung Bioepis Launch Epysqli, a 30% Discounted Biosimilar to Soliris for Rare Diseases
2年前
FDA Approves Epysqli, an Eculizumab Biosimilar for PNH and aHUS
去年
Novartis' FABHALTA Poised to Transform Treatment Landscape for Multiple Complement-Mediated Diseases
去年
Clinical Trials Advance Treatment for Rare Blood Disease aHUS, Offering Hope for Patients
去年
AstraZeneca Discontinues Two Alexion Rare Disease Programs Amid Strong Q4 Performance
去年
FDA Approves Soliris for Refractory Myasthenia Gravis, First New Treatment in 60 Years
第 1 页，共 315 页
上一页
下一页
